Three years of taking Crizotinib

Crizotinib (Crizotinib) is a targeted therapy drug mainly used to treat non-small cell lung cancer with positive ALK gene mutations. If the patient has been taking it for three years and has received effective treatment, the condition may be under control. However, if you experience serious side effects while taking crizotinib, your doctor may temporarily or permanently stop your treatment, reduce your dose, or reduce the number of times you take it.

However, it should be noted that long-term use of crizotinib may cause some adverse reactions, such as nausea, vomiting, diarrhea and other gastrointestinal symptoms, as well as liver and kidney function damage. Your doctor may give you another medicine to help prevent and treat nausea and vomiting, as well as a medicine to treat diarrhea. Therefore, patients should regularly monitor their physical condition while taking the medication and seek medical treatment in time if they feel unwell. At the same time, patients should take medications on time according to the doctor's recommendations and do not change the dosage or stop medication at will.

The original drug Crizotinib has been launched in China and is covered by medical insurance, but it is only reimbursed for patients who meet the indications. The price per box may be around RMB 15,000. The price of the original Turkish version of Crizotinib sold overseas may be more than RMB 10,000 per box (the price may fluctuate due to exchange rates), which is expensive. There are also cheaper generic crizotinib drugs available overseas. The ingredients are basically similar to those of the original drugs sold domestically and abroad. For example, the price of 250mg*60 tablets produced by a Bangladesh pharmaceutical factory may be more than 2,000 yuan per box (the price may fluctuate due to exchange rates).